Halla Nimeiri MD

Oncology•Chicago, IL

Associate Professor in Medicine-Hematology/Oncology, Northwestern University Feinberg Medical School

Join to View Full Profile

251 E Huron StChicago, IL 60611
Phone+1 312-926-2000
Fax+1 312-926-2411

Education & Training

University of ChicagoFellowship, Hematology and Medical Oncology, 2005 - 2008
Mercy Catholic Medical CenterResidency, Internal Medicine, 2002 - 2005
University of Khartoum Faculty of MedicineClass of 1992

Certifications & Licensure

IL State Medical License 2005 - 2026
PA State Medical License 2002 - 2005
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

Vitamin D Supplement in Preventing Colon Cancer in African Americans With Colon Polyps Start of enrollment: 2009 Feb 01
Terminated
Not Applicable
Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery Start of enrollment: 2009 Aug 01
Completed
Phase 2
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma Start of enrollment: 2009 Nov 17
Completed
Phase 1
E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer Start of enrollment: 2011 Nov 01
Terminated
Phase 1, Phase 2
Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery Start of enrollment: 2011 Dec 12
Completed
Phase 1, Phase 2
Study of Vitamin D in Untreated Metastatic Colorectal Cancer Start of enrollment: 2012 Apr 13
Completed
Phase 2
Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma Start of enrollment: 2012 Oct 05
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
A Tumor-Naïve ctDNA Assay Detects Minimal Residual Disease in Resected Stage II or III Colorectal Cancer and Predicts Recurrence: Subset Analysis from the GALAXY Study...
Yoshiaki Nakamura, Kristiyana Kaneva, Christine Lo, Daniel Neems, Jonathan E Freaney
Clinical Cancer Research. 2025-01-17
2 citations
Actionable Structural Variant Detection via RNA-NGS and DNA-NGS in Patients With Advanced Non-Small Cell Lung Cancer.
Dwight Owen, Rotem Ben-Shachar, Josephine Feliciano, Lisa Gai, Kyle A Beauchamp
JAMA Network Open. 2024-11-04
Dynamic Changes in Circulating Tumor Fraction as a Predictor of Real-World Clinical Outcomes in Solid Tumor Malignancy Patients Treated with Immunotherapy.
Ryan D Gentzler, John Guittar, Akash Mitra, Wade T Iams, Terri Driessen
Oncology and Therapy. 2024-09-01

Press Mentions

Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer CareNovember 11th, 2024
Tempus Expands Immuno-Oncology Portfolio with Launch of AI-Enabled, Multimodal Immune Profile Algorithmic TestsJuly 16th, 2024